Influence of divalent cations on regulation of cyclic GMP and cyclic AMP levels in brain tissue.
D000818:Animals; D001464:Barium / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology*; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism*; D003035:Cobalt / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D004533:Egtazic Acid / Q000494:pharmacology; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology*; D008345:Manganese / Q000494:pharmacology; D051379:Mice; D011188:Potassium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013324:Strontium / Q000494:pharmacology
D001464:Barium; D000001:Calcimycin; D003035:Cobalt; D008345:Manganese; D004533:Egtazic Acid; D012964:Sodium; D000242:Cyclic AMP; D006152:Cyclic GMP; D008274:Magnesium; D011188:Potassium; D002118:Calcium; D013324:Strontium